Pacific Biosciences of California (NASDAQ:PACB) read length capabilities and accuracy make its systems well-suited for very demanding applications. High-end sequencing company Pacific Biosciences of California (NASDAQ:PACB) still has much left to prove. The company has done a good job of improving system performance and reliability, but the 800lb gorilla in the sequencing space, Illumina (ILMN), books more orders for both its HiSeq and MiSeq platforms in a quarter than Pacific Biosciences of California (NASDAQ:PACB) has installed in the field. Pacific Biosciences of California (NASDAQ:PACB)’s alliance with Roche (OTCQX:RHHBY) provided a significant boost to the stock, but it has yet to be established that the company can develop systems and tests that will work in the clinical diagnostics setting. Pacific Biosciences of California (NASDAQ:PACB) stock performance was -5.11% in last session and finished the day at $5.39. Traded volume was 850.4K shares in the last session and the average volume of the stock remained 923.65K shares. The beta of the stock remained 2.51. Pacific Biosciences of California (NASDAQ:PACB) insider ownership is 2.60%.

Kevin Deierling, vice president of marketing for OrionVM’s technology partner Mellanox Technologies Ltd. (NASDAQ:MLNX), said: “OrionVM offers eight times more throughput with 10 times lower latency than comparable cloud IaaS providers based on 10 Gigabit Ethernet.” Mellanox Technologies, Ltd. (NASDAQ:MLNX) dropped -5.09 percent to $40.69 Tuesday on volume of 681.4K shares. The intra-day range of the stock was $40.31 to $42.79. Mellanox Technologies, Ltd. (NASDAQ:MLNX) has a market capitalization of $1.78billion.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of LIN Media LLC (“LIN” or the “Company”) (NYSE: LIN) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Media General, Inc. (NYSE: MEG), in a transaction valued at approximately $1.6 billion. Media General, Inc. (NYSE:MEG)’s stock on Mar 25, 2014 reported a decrease of -5.25% to the closing price of $17.67. Its fifty two weeks range is $5.56 -$23.97. The total market capitalization recorded $497.95million. The overall volume in the last trading session was 448.7K shares. In its share capital, MEG has 27.76million outstanding shares.

Vestas was the top-ranked foreign turbine maker in the Chinese market last year, Wu said, citing Chinese Wind Energy Association figures. The Danish turbine maker came 11th, taking 3.2 percent of the market, while Gamesa came 16th and GE 19th. Both had less than 2 percent. China’s Xinjiang Goldwind Science & Technology Co., Guodian United Power Technology Co. and China Ming Yang Wind Power Group Ltd (NYSE:MY) had the biggest shares. On Tuesday, shares of China Ming Yang Wind Power Group Ltd (NYSE:MY) dropped -6.99% to close the day at $3.06. Company return on investment (ROI) is -2.90% and its monthly performance is recorded as 14.61%. China Ming Yang Wind Power Group Ltd (NYSE:MY) quarterly revenue growth is 41.01%.